Focus: Flare Therapeutics is a public biotech company headquartered in Cambridge, MA, specializing in therapeutics that target transcription factors with a focus on oncology.
Profile data last refreshed 17h ago · AI intelligence enriched 2w ago
No open roles listed right now. Follow Flare Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
No open positions listed yet. Check their careers page directly.
Help build intelligence for Flare Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Flare Therapeutics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Based on last 4 crawl cycles
Recent peer-reviewed publications with author affiliations at this company
A small-molecule inverse agonist of PPARγ for advanced solid tumors: a phase 1 trial.
Ring systems in medicinal chemistry: A cheminformatics analysis of ring popularity in drug discovery over time.
Cancer epigenetic therapy: recent advances, challenges, and emerging opportunities.
Lysine Methyltransferase SMYD1 Regulates Myogenesis via skNAC Methylation.
Collaboration and knowledge integration for successful brain therapeutics - lessons learned from the pandemic.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo